If you consider realistic to be, trading in line with the rest of the depressed sector, and not apply a discount because it's OTC (I wouldn't do that) then I think we should be trading close to $2.50. You can use that as your first target if you want it to be.
This market is all about supply and demand. HERB is not on the radar now.
So any kind of news is welcome here. If they swap beans for oranges, so be it. But I see some other benefits as well. Asset validation. Reduction of complexity. This will make it easier to get a listing or spin it off in China. Or they may be able to get some loans. They for sure are not going dark with this company, otherwise why bother?
I still like the hemp stuff and maybe Angel Star will ramp up nicely in the next few years. Buyers could be around the corner, who really knows. But when the stock does move, I think it will move fast.
Recent HERB News
- Form C-AR - Annual Report • Edgar (US Regulatory) • 02/26/2024 01:00:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/12/2024 08:51:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/14/2023 07:00:08 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM